Patent Assignment
Reel/Frame 034863/0372
Assignment of Assignor's Interest
Recorded: 2015-01-30
Pages: 10
Assignor
INSPIRE PHARMACEUTICALS, INC.
Executed: 2014-10-23
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NEW JERSEY, 07065
Covered Properties
(38)
Method of Treating Bronchitis with Uridine Triphosphate and Related Compounds
Patent:
6,159,952 →
Application:
08/744,367 →
Method of Treating Dry Eye Disease with Uridine Triphosphates and Related Compounds
Patent:
5,900,407 →
Application:
08/797,472 →
Dinucleotides and Their Use as Modulators of Mucociliary Clearance and Ciliary Beat Frequency
Patent:
5,837,861 →
Application:
08/798,508 →
Certain Dinucleotides and Their Use as Modulators of Mucociliary Clearance and Ciliary Beat Frequency
Patent:
6,348,589 →
Application:
09/101,395 →
Method for Large-Scale Production of Di(Uridine 5'-Tetraphosphate) and Salts Thereof
Patent:
6,319,908 →
Application:
09/122,516 →
Method of Treating Dry Eye Disease with Purinergic Receptor Agonists
Patent:
6,887,858 →
Application:
09/171,169 →
Method of Promoting Cervical and Vaginal Secretions
Therapeutic Uses of Di(Uridine 5')-Tetraphosphate and Salts Thereof
Patent:
6,713,458 →
Application:
09/448,270 →
Method of Promoting Cervical and Vaginal Secretions
Patent:
7,432,252 →
Application:
09/531,851 →
Dinucleotide Tetraphosphate Crystals
Patent:
6,617,444 →
Application:
09/700,728 →
Use of Certain Dinucleotides to Stimulate Removal of Fluid in Retinal Detachment and Retinal Edema
Method for Large-Scale Production of Di(Uridine 5')-Tetraphosphate and Salts Thereof
Di(Uridine 5')-Tetraphosphate and Salts Thereof
Certain Dinucleotides and Their Use as Modulators of Mucociliary Clearance and Ciliary Beat Frequency
Method of Treating Dry Eye Disease with Purinergic Receptor Agonists
Method of Treating Dry Eye Disease with Purinergic Receptor Agonists
Method of Enhancing Drainage of Lacrimal System with Purinergic Receptor Agonists
Ectocornea Extension Promoters
Method of Treating Edematous Retinal Disorders
Di(Uridine 5')-Tetraphosphate and Salts Thereof
Method of Treating Edematous Retinal Disorders
Method for Large-Scale Production of Di(Uridine 5')-Tetraphosphate and Salts Thereof
Pharmaceutical Formulation Comprising Dinucleoside Polyphosphates and Salts Thereof
Di(Uridine 5'-)Tetraphosphate and Salts Thereof
Method of Enhancing Drainage of Lacrimal System with Purinergic Receptor Agonists
P2Y6 Receptor Agonists for Treating Lung Diseases
Di(Uridine 5'-)Tetraphosphate and Salts Thereof
P1-(2'-Deoxycytidine 5'-)P4-(Uridine 5'-)Tetraphosphate, Tetra-(Alkali Metal) Salt, for Treating Cystic Fibrosis
Method of Treating Dry Eye Disease with Purinergic Receptor Agonists
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition and Use
Di(Uridine 5'-)Tetraphosphate and Salts Thereof
P1-(2'-Deoxycytidine 5'-)P4-(Uridine 5'-)Tetraphosphate, Tetra-(Alkali Metal) Salt, for Treating Sinusitis
Method for Treating Cystic Fibrosis
Method of Increasing Tear Production with Purinergic Receptor Agonists
P2Y6 Receptor Agonists for Treating Lung Diseases
Bridged Bicyclic Rho Kinase Inhibitor Compounds, Composition and Use
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition and Use
Cytoskeletal Active Rho Kinase Inhibitor Compounds, Composition and Use
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License
Jan 19, 2017
From: THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 041413/0828 →
Confirmatory License
Feb 16, 2017
From: THE UNIVERISTY OF NORTH CAROLINA AT CHAPEL HILL
To: NATIONAL INSTITUTES OF HEALTH-DIRECTOR DEITR
Reel/Frame 041736/0270 →
Merger
Aug 8, 2022
From: MERCK SHARP & DOHME CORP.
To: MERCK SHARP & DOHME LLC
Reel/Frame 061102/0145 →